- Clinical Trials
- April 2025
- 60 Pages
Global
From €1138EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1138EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1138EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1138EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Report
- September 2024
- 132 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- August 2024
- 233 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1138EUR$1,250USD£966GBP
- Report
- June 2024
- 160 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- January 2025
- 180 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- June 2024
- 180 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 48 Pages
Global
From €3636EUR$3,995USD£3,088GBP
- Report
- March 2024
- 150 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- August 2023
- 150 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- December 2022
- 100 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- February 2023
- 260 Pages
Global
From €2548EUR$2,800USD£2,165GBP
- Report
- September 2021
- 40 Pages
China
From €2366EUR$2,600USD£2,010GBP
- Report
- July 2022
- 131 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- June 2023
- 159 Pages
Global
From €6826EUR$7,500USD£5,798GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more